Ascendis Pharma (ASND) has released an update. Ascendis Pharma has released its unaudited financial results for the period ending September 30, ...
Ascendis Pharma (ASND) has released an update. Ascendis Pharma reported a revenue of €57.8 million in Q3 2024, driven by product launches and ...
GlobalData on MSN18h
Metsera raises $215m in Series B round for weight loss candidatesMetsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback